Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    Cellerant
Show Display Options
Rank Status Study
1 Not yet recruiting Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Biological: CLT-008;   Biological: G-CSF
2 Completed Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma;   Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Intervention: Biological: human myeloid progenitor cells
3 Active, not recruiting Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myeloid Leukemia;   Myelodysplasia
Interventions: Biological: human myeloid progenitor cells;   Drug: G-CSF

Indicates status has not been verified in more than two years